Shanghai, China -- (SBWIRE) -- 10/27/2019 -- Latest research and development in the field of gene technology is leading to many innovations. The company leading the charge in this regard is GeniMedi. They are a gene company that primarily excels at viral vectors, gene therapy and mediated gene transfer.
Their adeno-associated virus vector, also known as their AAV packaging plasmid system is among their most powerful tools. Recently, GeniMedi showcased some developments and innovations they've made on this. It has thus been in the limelight.
The AAV expression system has many inserted expression cassettes. These contain a wide array of verified protomers and reporters. This includes GFP, zsgreen, RFP, mcherry and luciferase.
Many people believe that GeniMedi has opened new avenues with this technology. They are offering a multitude of advantages; the most notable one of which is safety. After the removal of most AAV genome elements, further security of the recombinant AAV is ensured. Genimedi also announced that this system features low immunogenicity. AAV causes a very mild immune response. This shows further evidence for its lack of pathogenicity.
Furthermore, it also offers other benefits like long-term stable expression and stable physical properties. As a result, GeneMedi's AAV Vector system is making a name for itself. GeniMedi's adeno-associated virus service is quickly becoming one of the finest. With so many benefits offered, there is little surprise in seeing this trend. GeniMedi continues to show innovation in their gene technology. They are aiming to providing even further developments. They believe that many more strides are possible in this field. And they wish to be at the zenith of it.
GeneMedi is a gene company with strong expertise in viral vectors, mediated gene transfer and gene therapy. GeneMedi helps scientists from academic and industrial backgrounds in high quality of adeno-associated virus (AAV) vector, lentivirus vector and adenovirus vector production. Genemedi also serves scientists for AAV vector system optimization, AAV vector transduction (AAV vector Gene Delivery in vivo), AAV capsid evolution and novel AAV generation.
They have manufactured the largest number of human full length protein-coding ORF cDNA clones in multiple types of viral vector systems (AAV, lentivirus, and adenovirus). This was with various features which make these clones suitable for a variety of viral packaging, functional assays, protein expression and easy purification in many cell types as well as cell-free transcription and translation coupling systems, and large scale functional genomics and proteomics studies. For more information: https://www.genemedi.net/